Research of the EML4-ALK Gene Expression in the Pleural Effusion or Tumor Tissue From Lung Cancer Patients

• Conditions: Lung Cancer Patients

• Registration Number: NCT01257308
• Lead Sponsor: Taipei Medical University WanFang Hospital

Brief Summary

We wants to analyse the EML4-ALK mutation rate in the patients who have non-small cell lung cancer.

Detailed Description

Not available

Study Timeline

• Study Start: 2010-08
• Status Verified: 2010-12
• Study First Submitted: 2010-12-08
• Study First Submitted QC: 2010-12-08
• Last Update Submitted: 2010-12-08
• Study First Posted: 2010-12-09
• Last Update Posted: 2010-12-09
• Study Completion: 2013-08

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• 20 or more than 20 years of age
• The pathological diagnosis confirmed lung cancer
• Patients have achieved pleural effusion, or surgical biopsy to obtain tumor tissue specimens
• The patient had signed inform consent

Exclusion Criteria

• pleural effusion or tumor tissue can not be obtained
• the patient is not suitable to join the research according to the judgement by the investigator

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Trial Locations

Locations (1)

Taipei Medical University - WanFang Hospital; 🇨🇳 Taipei, Taiwan